TY - JOUR T1 - Many US adults with controlled type 2 diabetes receive frequent HbA<sub>1c</sub> testing and possible overtreatment JF - Evidence Based Medicine JO - Evid Based Med SP - 98 LP - 98 DO - 10.1136/ebmed-2016-110414 VL - 21 IS - 3 AU - Neda Laiteerapong Y1 - 2016/06/01 UR - http://ebm.bmj.com/content/21/3/98.abstract N2 - Commentary on: McCoy RG, Van Houten HK, Ross JS, et al. HbA1c overtesting and overtreatment among US adults with controlled type 2 diabetes, 2001–13: observational population based study. BMJ 2015;351:h6138.Recent clinical guidelines have emphasised that patients with type 2 diabetes should have glycated haemoglobin (HbA1c) goals that are tailored to their individual clinical characteristics. Guidelines also recommend that patients with stable glycaemic control who are meeting their glycaemic goals and have no complications of glucose lowering should have less frequent HbA1c testing. The HbA1c reflects the average glucose over about 3 months and thus, at most, the HbA1c should be measured every 3 months. This epidemiologic study examines how frequently HbA1c levels are being tested in patients with type 2 diabetes and the potential clinical implications.This was a retrospective epidemiological study of national administrative claims data from commercially insured … ER -